Pfizer (PFE) Discusses Pipeline and AI Focus at Morgan Stanley

At the Morgan Stanley conference, Pfizer (PFE) highlighted its focus on pipeline advancements and artificial intelligence (AI) technologies. The company's strategy includes strengthening its presence in China, although no specific numbers or financial forecasts were provided. The emphasis on innovation and growth areas may impact investor confidence and future stock performance. Understanding Pfizer's initiatives could guide investors in assessing potential opportunities within the healthcare sector.